Janardan Khandekar to Prostatic Neoplasms
This is a "connection" page, showing publications Janardan Khandekar has written about Prostatic Neoplasms.
Connection Strength
0.190
-
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death. Eur Urol. 2017 05; 71(5):740-747.
Score: 0.060
-
Extragonadal seminoma involving urinary bladder and arising in the prostate. Cancer. 1993 Jun 15; 71(12):3972-4.
Score: 0.047
-
Biomarkers for the early detection of cancer: an inflammatory concept. Arch Intern Med. 2007 Sep 24; 167(17):1822-4.
Score: 0.032
-
Phase II study of cisplatin for metastatic prostatic carcinoma. An Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1983 Apr; 6(2):203-5.
Score: 0.023
-
Phase II evaluation of menogaril in advanced prostate cancer: Eastern Cooperative Oncology Group EST P-A885. Am J Clin Oncol. 2001 Apr; 24(2):150-4.
Score: 0.020
-
A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer. Cancer. 1985 Aug 01; 56(3):457-60.
Score: 0.007